glp-1 in heart failure JCI How GLP-1 Medications Reduce Heart
Description
A., Szabo M
The impact of diabetes on cognitive impairment and its progression to dementia
Combined sodium-glucose-transporters inhibitors and glucagon-like-peptide receptor agonist compared with monotherapy improves long-term survival: a real-world registry
A degraded semaglutide molecule cannot bind to GLP-1 receptors properly, which means reduced efficacy or no efficacy at all
Diagnostic Tools: Use CGMs, metabolic panels, and stool tests for personalized care
